col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


73 Ergebisse       Seite 1

 [1] 
Edizioni Internazionali srl, Divisione EDIMES Edizioni Medico-Scientifiche: Infezioni in Medicina
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mrz―10 Real-world experience with therapies for SARS-CoV-2: Lessons from the Italian COVID-19 studies
2 [GO] 2025―Jan―03 Evaluation of a training program on hand hygiene for healthcare workers in a second-level hospital in southern Italy during the COVID-19 pandemic
3 [GO] 2025―Jan―03 Updated WHO list of emerging pathogens for a potential future pandemic: Implications for public health and global preparedness
4 [GO] 2024―Sep―09 An examination of the influenza pandemic in early 20th century in Crete through the lens of the 1918 editions of Nea Ephimeris, a Cretan newspaper
5 [GO] 2024―Mai―30 The prevalence of long COVID-19 syndrome in hospitalized patients with COVID-19 pneumonia
6 [GO] 2024―Mai―30 COVID-19 vaccine-associated lymphadenopathy: a review
7 [GO] 2024―Mai―30 Antimicrobial therapies administrated during the Third Plague Pandemic in Europe
8 [GO] 2024―Mrz―05 COVID-19 vaccines-associated Takotsubo cardiomyopathy: A narrative review
9 [GO] 2024―Mrz―05 Investigating the diagnostic and prognostic value of anti-SARS-CoV-2 Spike IgG/IgM ELISA tests in patients infected with coronavirus Delta variant
10 [GO] 2023―Dez―06 Outcomes of COVID-19 amongst patients with ongoing use of inhaled corticosteroids - a systematic review & meta-analysis
11 [GO] 2023―Dez―06 Etiological characterization of acute undifferentiated febrile illness in Apartadó and Villeta municipalities, Colombia, during COVID-19 pandemic
12 [GO] 2023―Dez―06 Splenic infarction: an uncommon yet significant complication in COVID-19 patients - a case series report and literature review
13 [GO] 2023―Dez―06 Longitudinal evaluation of two different COVID-19 vaccination strategies in individuals with and without previous SARS-CoV-2 infection
14 [GO] 2023―Dez―06 Synergistic fight against future pandemics: Lessons from previous pandemics
15 [GO] 2023―Mrz―04 COVID-19 and tuberculosis coinfection: outcomes depend on severity of COVID-19 and comorbid conditions
16 [GO] 2023―Mrz―04 Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study
17 [GO] 2023―Mrz―04 The future for COVID-19 vaccines: public health assessment and perspectives based on scientific evidence
18 [GO] 2023―Mrz―04 Risk factors and outcomes of fungal superinfections in patients with severe COVID-19: an observational study from Pisa academic hospital
19 [GO] 2023―Mrz―04 Gingival presentation of mucormycosis post infection with COVID-19: series of 3 cases
20 [GO] 2023―Mrz―04 Invasive cryptococcal disease in COVID-19: systematic review of the literature and analysis
21 [GO] 2022―Dez―06 Prognostic evaluation of Acinetobacter baumannii ventilatorassociated pneumonia in COVID-19
22 [GO] 2022―Dez―06 COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study
23 [GO] 2022―Dez―06 Clinical impact of COVID-19 on tuberculosis
24 [GO] 2022―Dez―06 Corticosteroids use for COVID-19: an overview of systematic reviews
25 [GO] 2022―Dez―06 Detection of human adenovirus among Iranian pediatric hospitalized patients suspected of COVID-19: epidemiology and comparison of clinical features
26 [GO] 2022―Dez―06 Efficacy and safety of oral antivirals in individuals aged 80 years or older with mild-to-moderate COVID-19: preliminary report from an Italian Prescriber Center
27 [GO] 2022―Dez―06 Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy
28 [GO] 2022―Dez―06 The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends
29 [GO] 2022―Aug―30 Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online survey
30 [GO] 2022―Aug―30 Home management of COVID-19 symptomatic patients: a safety study on COVID committed home medical teams
31 [GO] 2022―Aug―30 Comparison of clinical characteristics and outcome in RT-PCR positive and false-negative RT-PCR for COVID-19: A Retrospective analysis
32 [GO] 2022―Aug―30 A comparative overview of SARS-CoV-2 and its variants of concern
33 [GO] 2022―Aug―30 MIS-C related to SARS-CoV-2 infection: a narrative review of presentation, differential diagnosis, and management
34 [GO] 2022―Aug―30 Are SARS-CoV-2 rapid antigen tests useful for the control of latest variants spreading?
35 [GO] 2022―Aug―30 The Manchurian pandemic of pneumonic plague (1910-1911)
36 [GO] 2022―Jun―08 Impact of COVID-19 severity on health-related quality of life among Saudi adult patients
37 [GO] 2022―Jun―08 Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study
38 [GO] 2022―Jun―08 Healthcare workers, epidemic biological risks - recommendations based on the experience with COVID-19 and Ebolavirus
39 [GO] 2022―Jun―08 Development of a nomogram to assess the impact of the myocardial injury on the prognosis of COVID-19 patients
40 [GO] 2022―Jun―08 Cutaneous complications of COVID-19 vaccines
41 [GO] 2022―Jun―08 Pathological involvement of placenta in COVID-19: a systematic review
42 [GO] 2022―Mrz―14 Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19
43 [GO] 2022―Mrz―14 Differential mortality with COVID-19 and invasive mechanical ventilation between high-income and low- and middle-income countries: a systematic review, meta-analysis, and meta-regression
44 [GO] 2022―Mrz―14 Comparison of COVID-19 characteristics in Egyptian patients according to their Toll-Like Receptor-4 (Asp299Gly) polymorphism
45 [GO] 2022―Mrz―14 The impact of COVID-19 on communicable and non-communicable diseases in Africa: a narrative review
46 [GO] 2022―Mrz―14 The serious threat of late presenters HIV-infected patients in the context of the COVID-19 pandemic
47 [GO] 2022―Mrz―14 Epidemiology of respiratory virus before and during COVID-19 pandemic
48 [GO] 2022―Mrz―14 Evolution of prescribing practices and outcomes in the COVID-19 pandemic in metropolitan areas
49 [GO] 2022―Mrz―14 Long Covid-19 syndrome as a fourth phase of Sars-CoV2 infection
50 [GO] 2022―Mrz―14 A review of adverse effects of COVID-19 vaccines
51 [GO] 2022―Mrz―14 COVID-19-induced immune thrombocytopenic purpura; Immunopathogenesis and clinical implications
52 [GO] 2022―Mrz―14 Liver involvement and mortality in COVID-19: A retrospective analysis from the CORACLE study group
53 [GO] 2022―Mrz―14 Can food matrices be considered as a potential carrier for COVID-19?
54 [GO] 2021―Dez―11 Pilot study on burden of fungal contamination in face masks: need for better mask hygiene in the COVID-19 era
55 [GO] 2021―Dez―11 Gastrointestinal manifestations in American minority population with COVID-19
56 [GO] 2021―Dez―11 Neutrophil-to-lymphocyte ratio and mean platelet volume in the diagnosis of bacterial infections in COVID-19 patients. A preliminary analysis from Ecuador
57 [GO] 2021―Dez―11 Global implication of booster doses of COVID-19 vaccine
58 [GO] 2021―Dez―11 Cranial neuropathy in COVID-19: a case series and review of literature
59 [GO] 2021―Dez―11 Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review
60 [GO] 2021―Dez―11 Mucormycosis in COVID-19: A systematic review of literature
61 [GO] 2021―Dez―11 Pneumocystis jirovecii pneumonia in breast cancer mimicking SARS-CoV-2 pneumonia during pandemic
62 [GO] 2021―Sep―17 Clinical profile, management and outcome of patients with leptospirosis during the times of COVID-19 pandemic: A prospective study from a tertiary care centre in South India
63 [GO] 2021―Sep―17 Association between RT-PCR Ct values and COVID-19 new daily cases: a multicenter cross-sectional study
64 [GO] 2021―Sep―17 COVID-19 infection after mRNA 1273 vaccine: review of the most frequently asked questions
65 [GO] 2021―Sep―17 SARS-CoV-2 variants of concern: implications on the second wave of COVID-19 in India
66 [GO] 2021―Sep―17 Sex differences in COVID-19 fatality rate and risk of death: An analysis in 73 countries, 2020-2021
67 [GO] 2021―Sep―17 A narrative review of emergency use authorization versus full FDA approval and its effect on COVID-19 vaccination hesitancy
68 [GO] 2021―Sep―17 Review of COVID-19 viral vector-based vaccines and COVID-19 variants
69 [GO] 2021―Sep―17 Current status of therapeutic alternatives for COVID-19: A narrative review
70 [GO] 2021―Sep―17 Myocardial injuries among patients with COVID-19: a systematic review
71 [GO] 2021―Sep―17 Can a quantitative assessment of SARS-CoV-2 PCR predict degree of severity and outcomes in critical care patients with COVID-19?
72 [GO] 2021―Sep―17 CURB-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with SARS-CoV-2 pneumonia
73 [GO] 2021―Sep―17 Epidemiological and clinical features of Spanish flu in the city of Ferrara and in Italy. Containment rules and health measures adopted in the past to fight the pandemic
 [1] 

73 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec